Preventive Effect of Low Molecuar Weight Heparin Sodiumon Renal Damages in Children with Henoch-Sch Nlein Purpura

Na He
2006-01-01
Abstract:Objective To investigate the clinical prevention effect of low molecular weight heparin sodium(LMWH)on renaldamages in children with Henoch-Sch nlein purpura(HSP)and to evaluate the safety of LMWH.Methods One-hundred and nine-ty-six paitents with HSP were divided randomlyinto LMWHtreat ment group(101 cases)and control group(95 cases),there werenot significant difference between two groups in age,sexes,course and diseases condition.All patients were treated withtagamet,vitamin C,vitamin P and calcium,but LMWHgroup received LMWHby intravenously(120-150u·kg-1·d-1)for 5-7d.Theti me of symptoms remission,the results of urine routine test,urine microprotien andβ2-mG were compared between two groups.Results There were 11(10.9 %)patients developing nephritis in LMWHgroup and 33(34.7 %)in control group respectively dur-ing 12 months following-up(P0.01).Side effects such as skin and mucosa bleeding did not appeared in the LMWHtreat mentgroup.Conclusion LMWHcan significantly reduce the incidence of Henoch-Schoenlein purpura nephritis(HSPN)and i mprove theprognosis of HSP.LMWHtreat ment is safety and effective.
What problem does this paper attempt to address?